Cargando…

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease

Advanced Glycation End Products (AGEs) are toxins that are involved in structural and functional alterations of several organs and tissues, resulting in various pathologies. Several types of AGEs have been described but carboxymethyllysine (CML) is the major antigenic AGE compound. In this study, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finco, Alessandra Becker, Machado-de-Ávila, Ricardo Andrez, Maciel, Rayana, De Moura, Juliana, Billiald, Philippe, Stinghen, Andrea Emilia Marques, Alvarenga, Larissa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600449/ https://www.ncbi.nlm.nih.gov/pubmed/28955871 http://dx.doi.org/10.1016/j.bbrep.2016.03.011

Ejemplares similares

Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs)
por: Rempel, Lisienny C. T., et al.
Publicado: (2015)

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential
por: Karim-Silva, Sabrina, et al.
Publicado: (2020)

Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018)

Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction
por: Fracasso, Bianca de Moraes, et al.
Publicado: (2019)

Use of a Synthetic Biosensor for Neutralizing Activity-Biased Selection of Monoclonal Antibodies against Atroxlysin-I, an Hemorrhagic Metalloproteinase from Bothrops atrox Snake Venom
por: Schneider, Francisco Santos, et al.
Publicado: (2014)

Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
por: Alvarenga, Larissa M., et al.
Publicado: (2014)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
por: Wendel, Ulrika, et al.
Publicado: (2018)

Engineering a single-chain antibody against Trypanosoma cruzi metacyclic trypomastigotes to block cell invasion
por: Demeu, Lara Maria Kalempa, et al.
Publicado: (2019)

Development of Nonalcoholic Hepatopathy: Contributions of Oxidative Stress and Advanced Glycation End Products
por: Santos, Juliana Célia de F., et al.
Publicado: (2013)

Vitamin D and chronic kidney disease: an uneasy relationship
por: Barreto, Fellype Carvalho, et al.
Publicado: (2020)

Development of Monoclonal Antibodies Specific for Glycated Prion Protein
por: Dvorakova, Eva, et al.
Publicado: (2011)

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives
por: Silveira, Gustavo de Bem, et al.
Publicado: (2021)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
por: Koerich, Suélyn, et al.
Publicado: (2023)

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
por: Sanguineti, Roberta, et al.
Publicado: (2014)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2017)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

In silico and in vitro Evaluation of Mimetic Peptides as Potential Antigen Candidates for Prophylaxis of Leishmaniosis
por: Guedes, Deborah Carbonera, et al.
Publicado: (2021)

Glycated Haemoglobin (HbA1c) Variations in Nondiabetics With Nutritional Anemia
por: Pilla, Rakesh, et al.
Publicado: (2020)

Classification epitopes in groups based on their protein family
por: Kozlova, Edgar Ernesto Gonzalez, et al.
Publicado: (2015)

Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
por: Portero-Otin, Manuel, et al.
Publicado: (2023)

Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis
por: Vytášek, Richard, et al.
Publicado: (2010)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Role of advanced glycation end products in cellular signaling()
por: Ott, Christiane, et al.
Publicado: (2014)

Vascular Effects of Dietary Advanced Glycation End Products
por: Stirban, Alin, et al.
Publicado: (2015)

Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Advanced Glycation End Products, Diabetes, and Bone Strength
por: Yamamoto, Masahiro, et al.
Publicado: (2016)

Association of advanced glycation end products in Dupuytren disease
por: Takase, Fumiaki, et al.
Publicado: (2018)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Advanced glycation end products and cognitive impairment in schizophrenia
por: Kobori, Akiko, et al.
Publicado: (2021)

Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
por: Oshitari, Toshiyuki
Publicado: (2023)

Advanced Glycation End-Products and Their Effects on Gut Health
por: Phuong-Nguyen, Kate, et al.
Publicado: (2023)

Influence of Physical Exercise on Advanced Glycation End Products Levels in Patients Living With the Human Immunodeficiency Virus
por: Rodrigues, Karine Lino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gpeafmr7udukvptld04q73ltd4